Brett Sandercock - 19 Aug 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
19 Aug 2021
Net transactions value
$0
Form type
4
Filing time
20 Aug 2021, 12:05:42 UTC
Previous filing
11 Aug 2021
Next filing
23 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +4,784 +5.6% $0.000000 89,786 19 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on August 19, 2021, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.